lymphoma, hodgkin
Showing 1 - 12 of 12
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Miltenyi CliniMACS Prodigy ® system
- (no location specified)
Mar 23, 2023
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)
Recruiting
- Acute Lymphoblastic Leukemia
- +12 more
-
Tucson, ArizonaThe University of Arizona Cancer Center
Dec 13, 2022
Lymphoma, B-Cell, Lymphoma, Hodgkin, Exercise Trial in Copenhagen (Resistance Exercise Training)
Recruiting
- Lymphoma, B-Cell
- +8 more
- Resistance Exercise Training
-
Copenhagen, DenmarkRigshospitalet
Oct 25, 2022
Leukemia, Myeloid, Acute, Leukemia, B-cell, Leukemia, T Cell Trial in Monza (Sport Therapy)
Recruiting
- Leukemia, Myeloid, Acute
- +7 more
- Sport Therapy
-
Monza, MB, ItalyMaria Letizia Verga Center, Pediatric Clinic, University of Mila
Oct 24, 2022
Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)
Recruiting
- Lymphoma
- +4 more
- Pharmacokinetics
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 12, 2022
Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln
Completed
- Lymphoma, Hodgkin
- +2 more
- Myo-Inositol and D-Chiro-Inositol (MIC)
-
Bari, ItalyIRCCS - Istituto Oncologico"Giovanni PaoloII"
Jun 2, 2022
Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin Trial (intervention)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- Lymphoma, Hodgkin
- intervention
- (no location specified)
Feb 9, 2022
Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Hodgkin Trial in France (MOOVCARE)
Terminated
- Lymphoma, T-Cell
- +2 more
- MOOVCARE
-
Vannes, Bretagne, France
- +14 more
Apr 2, 2021
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (OT-82 Dose Escalation, OT-82 Dose Expansion)
Recruiting
- Lymphoma
- +6 more
- OT-82 Dose Escalation
- OT-82 Dose Expansion
-
Birmingham, Alabama
- +7 more
Oct 22, 2020
Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin, Myeloma Trial in Monterrey (Plerixafor 0.12 mg/kg)
Unknown status
- Lymphoma, Non-Hodgkin
- +3 more
- Plerixafor 0.12 mg/kg
-
Monterrey, Nuevo Leon, MexicoServicio de Hematología Hospital Universitario "Dr. José Eleuter
Aug 9, 2017
Leukemia, Cancer, Lymphoma Trial in Houston (Ara C, Mesna, Cyclophosphamide)
Terminated
- Leukemia
- +4 more
- Ara C
- +3 more
-
Houston, TexasTexas Children's Hospital
Mar 24, 2016
MELT - MRI Evaluation of Lymphoma Treatment
Completed
- Lymphoma, Hodgkin
-
London, United KingdomUniversity College London Hospital (UCLH)
Dec 1, 2015